Content | Navigation |

Sponsored Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer Seminar Speakers

Upcoming Presentations 


“New Therapeutic Targets in Rare Cancers (NETs and MPNSTs)"
Monday, March 4
10:00 am
Sudro Hall 26
Dawn Quelle, Ph.D.
Associate Professor of Pharmacology, Leader, Cancer Genes and Pathways Program, Holden Comprehensive Cancer Center, Department of Pharmacology at the University of Iowa Carver College of Medicine

 

 

Past Presentations

Sushanta K. Banerjee, Ph.D., Research Scientist - VA Medical Center, Kansas City, MO, Research Director - Cancer Research Unit, VAMC, Professor - Department of Anatomy and Cell Biology and Department of Pathology University of Kansas Medical Center, Kansas City, Kansas 

  • “Targeting Triple Negative Breast Cancer by CCN5” - April 10, 2018

Kwaku Baryeh

  • “Carbon Nanotube-based Lateral Flow Biosensor Strips for the Quantitative Detection of Pancreatic Cancer Biomarkers in Human Plasma” (Dr. Liu’s group) - November 28, 2017
  • "Development of Lateral Flow Strip Biosensors for the Detection of Pancreatic Cancer Protein Biomarker: CA 19-9” (Dr. Liu’s group) - May 2, 2017

Dr. Howard Crawford, Professor, Molecular & Cellular Physiology and Internal Medicine; Director, Pancreas Research Program; Director, Animals Models of Pancreas Disease Core, University of Michigan

  • “Pancreatic Tumorigenesis:  When the Going Gets Tough, the Tufts Get Going” – October 11, 2016

Dr. Channing Der, Kenan Distinguished Professor of Pharmacology, Lineberger Comprehensive Cancer Center, the University of North Carolina at Chapel Hill

  • “Drugging Undruggable KRAS for Pancreatic Cancer” – October 28, 2016

Kevin P. Francis, Ph.D., Preclinical Imaging, PerkinElmer

  • April 18, 2017

Dr. Raghu Kalluri, Professor, and Chairman, Department of Cancer Biology, The University of Texas Anderson Cancer Center 

  • Date/Title Missing

Dr. Khoda

  • “Bio-manufacturing of Cancerous Pancreas Tissue with Controlled Gradient Scaffold Structure” - February 7, 2017

Dr. Sadagopan Krishnan, Department of Chemistry, Oklahoma State University

  • “Ultrasensitive Clinical Biosensors and Microarrays for Disease Markers” – August 29, 2016 

Dr. Estelle Leclerc

  • “Targeting RAGE in Pancreatic Cancer” - June 13, 2017

Qiaobin Li

  • “Gold/Silica Nanocomposite-based Lateral Flow Nucleic Acid Biosensors for Sensitive Detection of miRNA-196a” (Dr. Liu’s group) - March 21, 2017

Dr. Guodong Liu 

  • “Magnetic Carbon Nanotube for Visual Detection of Pancreatic Cancer Biomarkers in Whole Blood” - July 11, 2017

Jagadish Loganathan

  • “GSTP1 Regulation and JNK Activation in Pancreatic Cancer Cells” (Dr. Reindl’s group) - March 7, 2017 

Yi Lu, Ph.D., Department of Chemistry, Biochemistry, Bioengineering, Department of Materials Science and Engineering, and Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign

  • "Functional DNA Nanotechnology and Its Applications As Theranostic Agents for Sensing, Imaging and Targeted Drug Delivery in Cancer Research" - March 23, 2017

Michelle Lund

  • “Graphene Oxide Assisted SELEX for the Identification of Aptamers for Pancreatic Cancer Biomarkers” (Dr. Liu’s group) - February 21, 2017

Jiyan Mohammad

  • “CRISPR/Cas9 Loss-of-function Library Screen to Identify Genes that Regulate Sensitivity of Pancreatic Cancer Cells to Piperlongumine” (Dr. Reindl’s group) - December 12, 2017
  • “Organotypic and Next Generation Culture Methods” (Dr. Reindl’s group) - January 24, 2017

Dr. Mohi Quadir 

  • “Spatially-controlled, Combination Drug Delivery Platform Using pH-responsive Polymersomes for Pancreatic Cancer” - July 25, 2017

Dr. Steven Qian

  • “New Paradigm of COX-2 Biology on Its Interaction with omega-6s along with Delta-5 Desaturase Inhjibition in Revolutionizing Cancer Treatment” - January 9, 2018

Priyanka Ray

  • “pH Responsive Polymeric Nanoparticles as Efficient Drug Delivery Agents for Pancreatic Cancer” (Dr. Quadir's Group) - October 3, 2017 

Dr. Katie Reindl 

  • “Combination Therapy:  Targeting Pancreatic Cancer with a ROS Inducer and Gemcitabine” - June 27, 2017

Dr. Rajesh Sardar, Associate Professor, Department of Chemistry and Chemical Biology, Indiana University – Purdue University Indianapolis

  • “PCR-Free Pancreatic Cancer Biomarker Assay in Blood:  From Bench-top to Bedside” – November 3, 2016

Thomas D. Schmittgen, Ph.D., Professor of Pharmaceutics, University of Florida College of Pharmacy, Gainesville, Florida

  • “A MicroRNA and Pancreatic Cancer Link:  Implications for Therapy and Early Detection” - April 19, 2018

Rahul Singh

  • "GSTP1 knockdown and inhibition impairs pancreatic ductal adenocarcinoma growth (PDAC)" (Dr. Reindl’s group)  - May 2, 2017
  • “GSTP1 Knockdown Impairs the Growth and Proliferation of Pancreatic Ductal Adenocarcinoma (PDAC) Cells” (Dr. Reindl’s Group) - November 14, 2017

Dr. Silvia Stan, Assistant Professor, Department of Nutrition Science, Purdue University

  • “Insights into the Pleiotropic Nature of Dietary Bioactives” – October 21, 2016

Priyanka Swami

  • "Targeting RAGE in Pancreatic Cancer" (Dr. Leclerc’s group) - January 17, 2017
  • “Targeting RAGE in Pancreatic Cancer” (Dr. Leclerc’s Group) - October 17, 2017

Sunitha Takalkar

  • “Development of Lateral Flow Nucleic Acid Biosensors for the Detection of Pancreatic Cancer miRNA Biomarkers” (Dr. Liu’s group) - April 18, 2017

Sakshi Taneja

  • “In-vitro Study of AGE-RAGE Interaction on Pancreatic Cancer Using Prairie KPC Cell Lines” (Dr. Leclerc’s Group) - October 31, 2017 

Benjamin A. Teply, M.D., Assistant Professor, Internal Medicine, Division of Oncology & Hematology, UNMC Oncology/Hematology Division

  • “Therapeutic Opportunities in the Rapidly Changing Treatment Paradigm for Advanced Prostate Cancer" - July 16, 2018

Luke Theogarajan, Ph.D., Professor of Electrical and Computer Engineering, University of California, Santa Barbara

  • "Synthesis and Applications of Silicone-Based Amphiphilic Triblock Copolymers" - October 22, 2018

Daniel M. Tuvin, M.D., General Surgery, Surgical Oncology, Sanford Broadway Clinic

  • "The Current State of Diagnosis and Treatment of Pancreatic Cancer" - April 4, 2017

Dr. John Wilkinson

  • “Metabolic Regulation of Pancreatic Cancer by Apoptosis Including Factor” - January 10, 2017                  

Dr. Yan Zhang

  • “Manufacturing Pancreatic Cancer Tissue Microarrays Using 3D Tumor Spheroids” - January 17, 2017

Dr. Mohi Quadir

  • “Spatially-controlled, Combination Drug Delivery Platform Using pH-responsive Polymersomes for Pancreatic Cancer” - July 25, 2017

Student Focused. Land Grant. Research University.

Follow NDSU
  • Facebook
  • Twitter
  • RSS
  • Google Maps

North Dakota State University
Phone: +1 (701) 231-5192
Campus address: Sudro Hall 102
Physical/delivery address: 1401 Albrecht Blvd, 136 Sudro Hall, Fargo, ND 58102
Mailing address: NDSU Dept. 2665 / PO Box 6050 / Fargo, ND 58108-6050
Page manager: NDSU Department of Pharmaceutical Sciences

Last Updated: Wednesday, January 16, 2019 10:49:30 AM
Privacy Statement